CALM2 may bolster the activation of calcium/calmodulin-dependent kinase2 (CAMK2) and up-regulate MMP-9 production mediated by NF-κB and Akt, hence stepping up gastric cancer metastasis (35). Here, CAMK2B is linked to gastric cancer.